Given that HCV is a bloodborne virus, any circumstance that promotes continued drug injection—including failure to prevent or diagnose and adequately treat substance use disorders—can result in ...
Background.Controlling hepatitis C virus (HCV) transmission among people who inject drugs (PWID) has focused on preventing sharing syringes and drug preparation paraphernalia, but it is unclear ...
Hepatitis C, a liver-damaging viral infection, is on the rise in the United States, in large part because of the opioid crisis. According to the Centers for Disease Control and Prevention, the number ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Among injection ...
For injection drug users with hepatitis C virus (HCV) infection, providing treatment opportunities within a local needle exchange program can provide care to more patients and eventually cure more ...
The hepatitis C virus—HCV—can persist in the livers of those infected and even lead to liver disease or failure in extreme ...
Efforts to control blood-borne infections have dramatically reduced HIV incidence among injection drug users (IDUs), but declines in hepatitis C virus (HCV) infection have been less substantial, ...
People who inject drugs and are enrolled in a drug treatment program are receptive to learning about the hepatitis C virus and being treated for it, according to a study published last week. “One of ...
p. 889 Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection – D.M. Patrick Beginning in 1994, Vancouver experienced an explosive outbreak of HIV ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback